Skip to main content
Equibles
RGEN logo

RGEN · Repligen Corp · Metrics

Track RGEN — free

Use RGEN with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research RGEN.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$176.93 -1.78 (-1.00%) At close · Oct 23
S&P 400 member Russell 1000 member Rebalance outlook locked
Market Cap
$9.99B
Shares
56.44M
Volume · Oct 23 1.07M Avg daily vol (3M) 1.14M

RGEN metrics

98 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$176.93
Market cap
$9.99B

Price action

20 metrics
Price change (1W)
+0.9%
Price change (30D)
-6.7%
Price change (3M)
+34.1%
Price change (6M)
+50.5%
Price change (YTD)
+8.0%
Price change (1Y)
+7.1%
Trailing year
Price change (5Y)
-35.7%
52-week high
$194.57
52-week low
$102.87
Change from 52-week high
-9.1%
Change from 52-week low
+72.0%
Annualized volatility
46.1%
Annualized volatility (3M)
50.1%
Beta
1.2
RSI (14D)
49.5
Price vs SMA 50
-0.1%
Price vs SMA 200
+22.5%
Avg volume (3M)
1.14M
Relative volume
0.9
Average dollar volume
$195.55M

Company

3 metrics
Sector
Healthcare
Industry
Medical Instruments & Supplies
Shares outstanding
56.44M

Valuation

12 metrics
P / E (TTM)
239.1
Trailing earnings · reciprocal yield 0.4%
PEG ratio
—
EV / revenue
12.4×
reciprocal yield 8.1%
EV / EBITDA
67.8×
reciprocal yield 1.5%
EV / EBIT
150.5×
reciprocal yield 0.7%
P / sales
12.7×
reciprocal yield 7.9%
P / book
4.7
reciprocal yield 21.2%
FCF yield
1.1%
TTM · current market cap
Buyback yield
—
P / FCF
89.2
reciprocal yield 1.1%
P / operating cash flow
74.0
reciprocal yield 1.4%
Earnings yield
0.4%

Historical valuation

8 metrics
P / E historical average (3Y)
2,269.6×
reciprocal yield 0.0%
P / E historical average (5Y)
1,368.3×
reciprocal yield 0.1%
EV / revenue historical average (3Y)
22.7×
reciprocal yield 4.4%
EV / revenue historical average (5Y)
21.7×
reciprocal yield 4.6%
EV / EBIT historical average (3Y)
1,289.3×
reciprocal yield 0.1%
EV / EBIT historical average (5Y)
782.1×
reciprocal yield 0.1%
EV / EBITDA historical average (3Y)
89.6×
reciprocal yield 1.1%
EV / EBITDA historical average (5Y)
76.1×
reciprocal yield 1.3%

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-07-28

Profitability

9 metrics
Gross margin
53.5%
Operating margin
8.2%
Trailing 12 months
Net margin
5.3%
Gross profit (TTM)
$420.20M
Operating profit (TTM)
$64.61M
Net income (TTM)
$41.54M
Trailing 12 months
Diluted EPS (TTM)
$0.74
FCF margin
14.3%
Effective tax rate
20.3%

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$37.39

Growth

11 metrics
Revenue growth YoY
+11.9%
Year over year
Net income growth YoY
-66.3%
Revenue (TTM)
$785.10M
Trailing 12 months
EPS growth YoY
-65.4%
Shares change YoY
+0.2%
Year over year · more shares
Revenue CAGR (3Y)
-2.7%
Revenue CAGR (5Y)
+15.0%
EPS CAGR (3Y)
-35.7%
EPS CAGR (5Y)
-5.0%
FCF CAGR (3Y)
+2.5%
FCF CAGR (5Y)
+18.5%

Quality

14 metrics
Return on equity
2.0%
Return on assets
1.4%
Debt / equity
0.3
Current ratio
9.1
EBITDA (TTM)
$143.39M
Free cash flow (TTM)
$111.97M
Quick ratio
7.6
Interest coverage
2.9
Net debt / EBITDA
-1.8
Return on invested capital
2.8%
Trailing 12 months
Net cash
$259.40M
Latest balance sheet
Cash & equivalents
$606.78M
Total assets
$2.95B
Total debt
$551.05M

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$134.86M
Capital expenditures (TTM)
$22.90M
R&D (TTM)
$56.97M
SG&A (TTM)
$302.05M
Stock compensation (TTM)
$33.29M
R&D / revenue
7.3%
Stock compensation / revenue
4.2%

Ownership (13F)

9 metrics
13F filers
488
13F filer change QoQ
+40
Institutional ownership
118.4%
Conviction holders (share of 13F filers)
1.0%
Crowding (high-turnover and private-fund holders)
—
Private-fund adviser ownership
—
Active holders' share change QoQ
+1.2%
Holder tenure
15.5
Price vs estimated holder cost
-0.4%

Ownership (registered funds)

1 metrics
Index-fund ownership
19.8%

Short interest

3 metrics
Short interest
13.4%
Latest settlement · 6.6 days to cover
Days to cover
6.6d
Short-squeeze score
84 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$5.95M
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 730272 CUSIP 759916109 13F (30d) 90 filings 85 filers Visit website Investor relations